NCT02981602 - Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

December 18, 2019

Study Completion Date

December 26, 2019

Conditions

Hepatitis BChronic Hepatitis B Atypical

Interventions

DRUG

IONIS-HBVRx

Ascending multiple doses of IONIS-HBVRx by subcutaneous (SC) injection

DRUG

Placebo

Trial Locations (7)

Queen Mary Hospital, Hong Kong

Korea University Ansan Hospital, Ansan

Inje University Busan Paik Hospital, Busan

Kyungpook National University Hospital, Daegu

Pusan National University Hospital, Pusan

Seoul National University Hospital, Seoul

Seoul St. Mary's Hospital, Seoul